| Literature DB >> 35603074 |
Ahmed E Mahmoud1, Mamdouh M El-Maghraby1, Reham M Eltarabili2, Essam S Soliman3.
Abstract
Background: Feline lower urinary tract disease (FLUTD) is a common disorder associated with the dysfunction of the urinary bladder or urethra in tomcats. Aim: A prospective study was carried out on the point prevalence and odds ratio (OR) of the FLUTD in Shirazi and Baladi tomcats at Ismailia Governorate, Egypt, recording the prominent clinical manifestation and identifying the antibiogram, virulence, and antimicrobial resistance genes of the causative microorganisms.Entities:
Keywords: Antibiotic resistance; Crystals; Feline lower urinary tract disease; Prevalence; Virulence
Mesh:
Substances:
Year: 2022 PMID: 35603074 PMCID: PMC9109839 DOI: 10.5455/OVJ.2022.v12.i2.18
Source DB: PubMed Journal: Open Vet J ISSN: 2218-6050
Primers and amplicon sizes of the amplified products and specific annealing temperatures.
| M.Os | Target gene | Primers sequences | Amplicon size (bp) | Amplification (35 cycles) | ||
|---|---|---|---|---|---|---|
| Denaturation | Annealing | Extension | ||||
| E. coli |
| TGCAGAACGGATAAGCCGTGG | 508 | 94°C | 50°C | 72°C |
|
| TGATATCACGCACTCAGTAGC | 501 | 94°C | 58°C | 72°C | |
|
| ATGTTATTTTCTGCCGCTCTG | 226 | 94°C | 54°C | 72°C | |
|
| GGCTGGACATGGGAACTGG | 300 | 94°C | 63°C | 72°C | |
|
| ATG TGC AGY ACC AGT AAR GTK ATG GC | 593 | 94°C | 54°C | 72°C | |
|
| ATCAGCAATAAACCAGC | 516 | 94°C | 54°C | 72°C | |
|
| GGTTCACTCGAACGACGTCA | 576 | 94°C | 50°C | 72°C | |
| S. aureus |
| GTA GAA ATG ACT GAA CGT CCG ATA A | 310 | 94°C | 50°C | 72°C |
|
| ATA GAG ATG CTG GTA CAG G | 630 | 94°C | 55°C | 72°C | |
|
| TCA ACA AAG AAC AAC AAA ATG C | 226 | 94°C | 50°C | 72°C | |
|
| GTAGCGACAATAGGTAATAGT | 364 | 94°C | 54°C | 72°C | |
Prevalence and odds ratio of FLUTD’s contributing causes (pyogenic, crystals, and mixed cases) in Shirazi and Baladi tomcats.
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|
| Shirazi Tomcat | Baladi Tomcat | |||||||
| ≤2 | 2: 4 | >4 | ≤2 | 2: 4 | >4 | |||
|
| ||||||||
|
|
| 9 | 9 | 12 | 9 | 9 | 13 |
|
| PP | 12.86b | 12.86b | 17.14a | 12.86b | 12.86b | 18.57a | 0.012 | |
| OR | 5.36b | 6.52b | 27.27a | 2.65c | 10.71b | 21.67a | 0.001 | |
|
|
| 4 | 4 | 0 | 5 | 2 | 1 | --- |
| PP | 5.71a | 5.71a | 0.00b | 7.14a | 2.86b | 1.43c | 0.001 | |
| OR | 1.06a | 0.72b | 0.19c | 0.82a | 0.53b | 0.13c | 0.000 | |
|
| ||||||||
|
|
| 3 | 5 | 5 | 12 | 7 | 4 |
|
| PP | 4.29b | 7.14a | 7.14a | 17.14a | 10.00b | 5.71c | 0.005 | |
| OR | 0.68c | 1.19b | 1.32a | 2.68a | 2.57a | 0.55b | 0.001 | |
|
|
| 0 | 0 | 2 | 1 | 1 | 4 | --- |
| PP | 0.00b | 0.00b | 2.86a | 1.43b | 1.43b | 5.71a | 0.002 | |
| OR | 0.00b | 0.00b | 0.40a | 0.09c | 0.21b | 0.55a | 0.000 | |
|
|
| 1 | 3 | 3 | 3 | 2 | 3 | --- |
| PP | 1.43b | 4.29a | 4.29a | 4.29a | 2.86b | 4.29a | 0.007 | |
| OR | 0.19c | 0.60b | 0.66a | 0.32c | 0.45a | 0.38b | 0.001 | |
|
|
| 10 | 7 | 5 | 4 | 5 | 7 | --- |
| PP | 14.29a | 10.00b | 7.14c | 5.71c | 7.14b | 10.00a | 0.002 | |
| OR | 6.25a | 2.08b | 1.32c | 0.45c | 1.47a | 1.22b | 0.000 | |
|
| ||||||||
|
|
| 4 | 6 | 7 | 9 | 6 | 11 |
|
| PP | 5.71c | 8.57b | 10.00a | 12.86b | 8.57c | 15.71a | 0.001 | |
| OR | 1.06c | 1.34b | 1.85a | 0.95c | 1.92a | 1.43b | 0.000 | |
|
| n | 3 | 2 | 0 | 5 | 0 | 1 | --- |
| PP | 4.29a | 2.86b | 0.00b | 7.14a | 0.00c | 1.43b | 0.000 | |
| OR | 0.79a | 0.45b | 0.00c | 0.53a | 0.00c | 0.13b | 0.000 | |
Means with different superscripts in the same row are significantly different at p ≤ 0.05 or highly significantly different at p < 0.01. Means with the same superscripts in the same row are nonsignificantly different at p< 0.05. Total number of cases caused by crystals = 43; pyogenic microorganisms = 23; and mixed cases = 54. The recorded crystals were amorphous urate = 36; calcium oxalate = 8; amorphous phosphate = 15; and triple phosphate = 38. PP: Point prevalence; OR: Odds ratio; E. coli: Escherichia coli, S. aureus: Staphylococcus aureus; SE: Standard error.
Antimicrobial susceptibility of the recovered isolates.
|
|
| S. aureus ( | |||||
|---|---|---|---|---|---|---|---|
|
| AMX | 2 (8.3) | 2 (8.3) | 20 (83.4) | 3 (14.2) | 0 (0) | 18 (85.8) |
| AMC | 3 (12.5) | 6 (25.0) | 15 (62.5) | 3 (14.2) | 3 (14.2) | 14 (66.6) | |
| OXA | 6 (25.0) | 5 (20.8) | 13 (54.1) | 2 (9.6) | 0 (0) | 21 (100) | |
|
| CAZ | 0 (0) | 6 (25.0) | 18 (75.0) | 5 (23.8) | 0 (0) | 16 (76.2) |
| CTR | 4 (16.6) | 0 (0) | 20 (83.4) | 9 (42.9) | 3 (14.2) | 9 (42.9) | |
| FOX | 6 (25.0) | 6 (25.0) | 12 (50.0) | 2 (9.6) | 0 (0) | 21 (100) | |
|
| NOR | 12 (50.0) | 7 (29.2) | 5 (20.8) | 14 (66.6) | 0 (0) | 7 (33.4) |
|
| ATM | 14 (58.4) | 6 (25.0) | 4 (16.6) | 13 (62.0) | 3 (14.2) | 5 (32.8) |
|
| AK | 16 (41.6) | 8 (33.4) | 0 (0) | 19 (90.4) | 1 (4.7) | 1 (4.7) |
| GEN | 18 (75.0) | 0 (0) | 6 (25.0) | 10 (47.6) | 6 (28.6) | 5 (32.8) | |
|
| MEM | 21 (87.5) | 3 (12.5) | 0 (0) | 21 (100) | 0 (0) | 0 (0) |
|
| NIT | 20 (83.4) | 3 (12.5) | 1 (4.1) | 15 (71.4) | 3 (14.2) | 0 (0) |
|
| DOX | 8 (33.4) | 6 (25.0) | 10 (41.6) | 9 (42.9) | 3 (14.2) | 9 (42.9) |
|
| SXT | 12 (50.0) | 0 (0) | 12 (50.0) | 10 (47.6) | 0 (0) | 11 (52.4) |
| 10.14a±1.860 | 4.143a±0.7402 | 9.714a±1.908 | 9.643a±1.663 | 1.571a±0.5105 | 9.786a±1.962 | ||
Asignificant difference at p < 0.0001; AMX: Amoxicillin; AMC: Amoxicillin and clavulanic acid; OXA: Oxacillin; CAZ: Ceftazidime; CTR: Ceftriaxone; FOX: Cefoxitin; NOR: Norfloxacin; ATM: Aztreonam; AK: Amikacin; GEN: Gentamicin; MEM: Meropenem; NIT: Nitrofurntin; DOX: Doxycycline; SXT: Trimethoprim-sulfamethoxazole.
The distribution of the virulence genes and antibiotic resistance genes among the recovered strains of E. coli and S. aureus.
| M.Os | Type of genes | Genes of | No. | % | Chi-square |
|---|---|---|---|---|---|
|
| Virulence genes | 21 | 87.5 | 9.1009NS | |
|
| 18 | 75.0 | |||
| 13 | 54.2 | ||||
| 9 | 37.5 | ||||
| Antibiotic resistance genes |
| 20 | 83.4 | ||
|
| 18 | 75.0 | |||
| 10 | 41.6 | ||||
|
| Virulence genes |
| 21 | 100 | 0.34177NS |
| 21 | 100 | ||||
| Antibiotic resistance genes |
| 18 | 85.7 | ||
| 9 | 42.9 |
Fig. 1.Antibiotics’ sensitivity patterns in the isolated E. coli and S. aureus.
Fig. 2.(A) PCR amplification of the specific gene of S. aureus (coa) at 630 bp. (B) PCR amplification of the specific gene of S. aureus (spa) at 226 bp. (C) PCR amplification of the specific gene of S. aureus (mecA) at 310 bp. (D) PCR amplification of the specific gene of S. aureus (tetK) at 364 bp.
Fig. 3.(A) PCR amplification of the specific gene of E. coli (iutA) at 300 bp. (B) PCR amplification of the specific gene of E. coli (iss) at 226 bp. (C) PCR amplification of the specific gene of E. coli (papC) at 501 bp. (D) PCR amplification of the specific gene of E. coli (fimH) at 508 bp.
Fig. 4.(A) PCR amplification of the specific gene of E. coli (blaCTX-M) at 593 bp. (B) PCR amplification of the specific gene of E. coli (blaTEM) at 516 bp. (C) PCR amplification of the specific gene of E. coli (tetA) at 576 bp.
The frequency of the phenotypic multidrug resistance and the antibiotic resistance genes among the retrieved strains of E. coli and S. aureus.
| Type of bacteria | No. of strains | % | Type of resistance | Phenotypic multidrug resistance | MAR | Antimicrobial resistance genes |
|---|---|---|---|---|---|---|
|
| 12 | 50.0 | MDR | Penicillins: AMX, AMC, OXA | 0.29 | |
| 6 | 25.0 | MDR | Penicillins: AMX | 0.20 | ||
| 3 | 12.5 | MDR | Penicillins: AMC | 0.16 |
| |
| 2 | 8.3 | MDR | Penicillins: AMX | 0.12 |
| |
| 1 | 4.1 | MDR | Penicillins: OXA | 0.20 |
| |
|
| 11 | 52.4 | MDR | Penicillins: AMX, AMC, OXA | 0.28 |
|
| 5 | 32.8 | XDR | Penicillins: OXA | 0.38 |
| |
| 2 | 9.6 | MDR | Penicillins: AMX, OXA | 0.28 |
| |
| 2 | 9.6 | MDR | Penicillins: AMC, OXA | 0.23 |
| |
| 1 | 4.7 | MDR | Penicillins: AMC, OXA | 0.19 |
MDR: multidrug resistance; XDR: extensively drug-resistance; AMX: Amoxicillin; AMC: Amoxicillin and clavulanic acid; OXA: Oxacillin; CAZ: Ceftazidime; CTR: Ceftriaxone; FOX: Cefoxitin; NOR: Norfloxacin; ATM: Aztreonam; AK: Amikacin; GEN: Gentamicin; MEM: Meropenem; NIT: Nitrofurntin; DOX: Doxycycline; SXT: Trimethoprim-sulfamethoxazole.